48.00GBp-3.81%Mkt Cap: 34.77M GBpP/E: —Last update: 2026-06-01
Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmenta…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap34.77M GBp
Enterprise Value26.43M GBp
Revenue (TTM)20.03M GBp
Gross Profit12.61M GBp
Net Income (TTM)-22.88M GBp
Revenue/Share0.2840 GBp
Last Price48.00 GBp
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees224
CountryGB
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.07
PEG—
EV/EBITDA10.19
EV/Revenue1.32
P/S1.80
P/B0.86
EPS (TTM)-0.33
EPS (Forward)-6.96
52W Range
26.6036% of range86.00
52W High86.00 GBp
52W Low26.60 GBp
Profitability
Gross Margin62.98%
Oper. Margin-59.36%
EBITDA Margin12.95%
Profit Margin-114.25%
ROE-97.91%
ROA-56.74%
Growth
Revenue Growth6.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.01M GBp
CapEx (TTM)881.00K GBp
FCF Margin36.82%
FCF Yield21.21%
Net Debt-8.81M GBp
Net Debt/EBITDA-3.40
Balance Sheet
Debt/Equity0.45
Current Ratio4.75
Quick Ratio4.16
Book Value/Sh0.5780 GBp
Cash/Share0.2730 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)6600.00 GBp
Target Range6600.00 GBp – 6600.00 GBp
# Analysts1
Ownership
Shares Out.72.44M
Float70.41M
Insiders0.06%
Institutions0.00%
Technical
SMA 5038.36 (+25.1%)
SMA 20037.79 (+27.0%)
Beta0.93
S&P 52W Chg27.94%
Avg Vol (30d)675.76K
Avg Vol (10d)858.21K
Technical Indicators
RSI (14)53.9
MACD3.8504
MACD Signal4.4924
MACD Hist.-0.6420
BB Upper73.16 GBp
BB Middle47.60 GBp
BB Lower22.04 GBp
BB Width107.41%
ATR (14)8.312 GBp
Vol Ratio (20d)0.16x